Infectivity of Lactobacillus rhamnosus and Lactobacillus paracasei isolates in a rat model of experimental endocarditis

Journal of Medical Microbiology

Volumn 56, Issue 8, 2007, Pages 1017-1024

  Vankerckhoven, Vanessa ^a   Moreillon, Philippe ^b   Piu, Stéphane ^b   Giddey, Marlyse ^b   Huys, Geert ^c   Vancanneyt, Marc ^d   Goossens, Herman ^a,e   Entenza, José M ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c GHENT UNIVERSITY   (Belgium)

^d GHENT UNIVERSITY   (Belgium)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA THROMBOGLOBULIN; COLLAGEN; FIBRINOGEN; FIBRINOPEPTIDE A; FIBRONECTIN; LAMININ; MICROBICIDE; PROBIOTIC AGENT;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BACTERIUM ISOLATE; COLONY FORMING UNIT; CONTROLLED STUDY; ENDOCARDITIS; FLUORESCENCE; GENE AMPLIFICATION; GENE CLUSTER; LACTOBACILLUS PARACASEI; LACTOBACILLUS RHAMNOSUS; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; RAT; STRAIN DIFFERENCE;

ANIMALS; BACTERIAL ADHESION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCARDITIS, BACTERIAL; FEMALE; FIBRINOPEPTIDE A; HUMANS; LACTOBACILLUS; LACTOBACILLUS RHAMNOSUS; PEPTIDES; PROBIOTICS; RATS; RATS, WISTAR; SPECIES SPECIFICITY; VIRULENCE;

EID: 34547880413     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.46929-0     Document Type: Article

References (46)

1. Aguirre, M. & Collins, M. D. (1993). Lactic acid bacteria and human clinical infection. J Appl Bacteriol 75, 95-107.
2. Alvarez-Olmos, M. I. & Oberhelman, R. A. (2001). Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin Infect Dis 32, 1567-1576.
3. Asahara, T., Takahashi, M., Nomoto, K., Takayama, H., Onoue, M., Morotomi, M., Tanaka, R., Yokokura, T. & Yamashita, N. (2003). Assessment of safety of lactobacillus strains based on resistance to host innate defense mechanisms. Clin Diagn Lab Immunol 10, 169-173.
4. Avlami, A., Kordossis, T., Vrizidis, N. & Sipsas, N. V. (2001). Lactobacillus rhamnosus endocarditis complicating colonoscopy. J Infect 42, 283-285.
5. Borriello, S. P., Hammes, W. P., Holzapfel, W., Marteau, P., Schrezenmeir, J., Vaara, M. & Valtonen, V. (2003). Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 36, 775-780.
6. Brogden, K. A. (2005). Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3, 238-250.
7. Bulet, P., Stocklin, R. & Menin, L. (2004). Antimicrobial peptides: from invertebrates to vertebrates. Immunol Rev 198, 169-184.
8. Cannon, J. P., Lee, T. A., Bolanos, J. T. & Danziger, L. H. (2005). Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis 24, 31-40.
9. Carbon, C. (1993). Experimental endocarditis: a review of its relevance to human endocarditis. J Antimicrob Chemother 31, 71-85.
10. Carr, F. J., Chill, D. & Maida, N. (2002). The lactic acid bacteria: a literature survey. Crit Rev Microbiol 28, 281-370.
11. Dankert, J., van der Werff, J., Zaat, S. A., Joldersma, W., Klein, D. & Hess, J. (1995). Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis. Infect Immun 63, 663-671.
12. Dellaglio, F., Felis, G. E. & Torriani, S. (2002). The status of the species Lactobacillus casei (Orla-Jensen 1916) Hansen and Lessel 1971 and Lactobacillus paracasei Collins et al. 1989. Request for an opinion. Int J Syst Evol Microbiol 52, 285-287.
13. Dicks, L. M., Du Plessis, E. M., Dellaglio, F. & Lauer, E. (1996). Reclassification of Lactobacillus casei subsp. casei ATCC 393 and Lactobacillus rhamnosus ATCC 15820 as Lactobacillus zeae nom. rev., designation of ATCC 334 as the neotype of L. casei subsp. casei, and rejection of the name Lactobacillus paracasei. Int J Syst Bacteriol 46, 337-340.
14. B in the expression of Staphylococcus aureus cell wall adhesins ClfA and FnbA and contribution to infectivity in a rat model of experimental endocarditis. Infect Immun 73, 990-998.
15. Fingold, S. M., Sutter, V. L. & Mathisen, G. E. (1983). Normal indigenous intestinal flora. In Human Intestinal Microflora in Health and Disease, pp. 3-31. Edited by D. J. Hentges. London: Academic Press.
16. Fowler, V. G., Jr, McIntyre, L. M., Yeaman, M. R., Peterson, G. E., Barth, R. L., Corey, G. R., Wray, D. & Bayer, A. S. (2000). In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source. J Infect Dis 182, 1251-1254.
17. Gasser, F. (1994). Safety of lactic acid bacteria and their occurrence in human clinical infections. Bull Inst Pasteur 92, 45-67.
18. Glauser, M. P., Bernard, J. P., Moreillon, P. & Francioli, P. (1983). Successful single-dose amoxicillin prophylaxis against experimental streptococcal endocarditis: evidence for two mechanisms of protection. J Infect Dis 147, 568-575.
19. Harty, D. W. S., Patrikakis, M. & Knox, K. W. (1993). Identification of Lactobacillus strains isolated from patients with infective endocarditis and comparison of their surface-associated properties with those of other strains of the same species. Microb Ecol Health Dis 6, 191-201.
20. Heraief, E., Glauser, M. P. & Freedman, L. R. (1982). Natural history of aortic valve endocarditis in rats. Infect Immun 37, 127-131.
21. Husni, R. N., Gordon, S. M., Washington, J. A. & Longworth, D. L. (1997). Lactobacillus bacteremia and endocarditis: review of 45 cases. Clin Infect Dis 25, 1048-1055.
22. Huys, G., Vancanneyt, M., D'Haene, K., Vankerckhoven, V., Goossens, H. & Swings, J. (2006). Accuracy of species identity of commercial bacterial cultures intended for probiotic or nutritional use. Res Microbiol 157, 803-810.
23. Krijgsveld, J., Zaat, S. A., Meeldijk, J., van Veelen, P. A., Fang, G., Poolman, B., Brandt, E., Ehlert, J. E., Kuijpers, A. J. & other authors (2000). Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines. J Biol Chem 275, 20374-20381.
24. Land, M. H., Rouster-Stevens, K., Woods, C. R., Cannon, M. L., Cnota, J. & Shetty, A. K. (2005). Lactobacillus sepsis associated with probiotic therapy. Pediatrics 115, 178-181.
25. MacKay, A. D., Taylor, M. B., Kibbler, C. C. & Hamilton-Miller, J. M. (1999). Lactobacillus endocarditis caused by a probiotic organism. Clin Microbiol Infect 5, 290-292.
26. Mikelsaar, M. & Mändar, R. (1993). Development of individual lactic acid bacteria in the human microbial ecosystem. In Lactic Acid Bacteria, pp. 237-294. Edited by S. Salminen & A. von Wright. New York: Marcel Dekker.
27. Moreillon, P. & Que, Y. A. (2004). Infective endocarditis. Lancet 363, 139-149.
28. Moreillon, P., Entenza, J. M., Francioli, P., McDevitt, D., Foster, T. J., Francois, P. & Vaudaux, P. (1995). Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun 63, 4738-4743.
29. Moreillon, P., Que, Y. A. & Bayer, A. S. (2002). Pathogenesis of streptococcal and staphylococcal endocarditis. Infect Dis Clin North Am 16, 297-318.
30. Oakey, H. J., Harty, D. W. & Knox, K. W. (1995). Enzyme production by lactobacilli and the potential link with infective endocarditis. J Appl Bacteriol 78, 142-148.
31. Presterl, E., Kneifel, W., Mayer, H. K., Zehetgruber, M., Makristathis, A. & Graninger, W. (2001). Endocarditis by Lactobacillus rhamnosus due to yogurt ingestion? Scand J Infect Dis 33, 710-714.
32. Que, Y. A., Francois, P., Haefliger, J. A., Entenza, J. M., Vaudaux, P. & Moreillon, P. (2001). Reassessing the role of Staphylococcus aureus clumping factor and fibronectin-binding protein by expression in Lactococcus lactis. Infect Immun 69, 6296-6302.
33. Que, Y. A., Haefliger, J. A., Piroth, L., Francois, P., Widmer, E., Entenza, J. M., Sinha, B., Herrmann, M., Francioli, P. & other authors (2005). Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis. J Exp Med 201, 1627-1635.
34. Rautio, M., Jousimies-Somer, H., Kauma, H., Pietarinen, I., Saxelin, M., Tynkkynen, S. & Koskela, M. (1999). Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis 28, 1159-1160.
35. Salminen, M. K., Tynkkynen, S., Rautelin, H., Saxelin, M., Vaara, M., Ruutu, P., Sarna, S., Valtonen, V. & Jarvinen, A. (2002). Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis 35, 1155-1160.
36. Salminen, M. K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V. & Jarvinen, A. (2006). Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clin Infect Dis 42, e35-e44.
37. Schillinger, U., Guigas, C. & Holzapfel, W. H. (2005). In vitro adherence and other properties of lactobacilli used in probiotic yoghurt-like products. Int Dairy J 15, 1289-1297.
38. Soleman, N., Laferl, H., Kneifel, W., Tucek, G., Budschedl, E., Weber, H., Pichler, H. & Mayer, H. K. (2003). How safe is safe? - A case of Lactobacillus paracasei ssp. paracasei endocarditis and discussion of the safety of lactic acid bacteria. Scand J Infect Dis 35, 759-762.
39. Stutzmann Meier, P., Entenza, J. M., Vaudaux, P., Francioli, P., Glauser, M. P. & Moreillon, P. (2001). Study of Staphylococcus aureus pathogenic genes by transfer and expression in the less virulent organism Streptococcus gordonii. Infect Immun 69, 657-664.
40. Styriak, I., Nemcova, R., Chang, Y. H. & Ljungh, A. (2003). Binding of extracellular matrix molecules by probiotic bacteria. Lett Appl Microbiol 37, 329-333.
41. Tang, Y. Q., Yeaman, M. R. & Selsted, M. E. (2002). Antimicrobial peptides from human platelets. Infect Immun 70, 6524-6533.
42. Vancanneyt, M., Huys, G., Lefebvre, K., Vankerckhoven, V., Goossens, H. & Swings, J. (2006). Intraspecific genotypic characterization of Lactobacillus rhamnosus strains intended for probiotic use and isolates of human origin. Appl Environ Microbiol 72, 5376-5383.
43. Vankerckhoven, V., Van Autgaerden, T., Huys, G., Vancanneyt, M., Swings, J. & Goossens, H. (2004). Establishment of the PROSAFE collection of probiotic and human lactic acid bacteria. Microb Ecol Health Dis 16, 131-136.
44. WHO & FAO (2001). Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Report of a joint FAO/WHO expert consultation. Geneva: World Health.
45. Yeaman, M. R. (1997). The role of platelets in antimicrobial host defense. Clin Infect Dis 25, 951-968.
46. Ze-Ze, L., Tenreiro, R., Duarte, A., Salgado, M. J., Melo-Cristino, J., Lito, L., Carmo, M. M., Felisberto, S. & Carmo, G. (2004). Case of aortic endocarditis caused by Lactobacillus casei. J Med Microbiol 53, 451-453.